Installation of Elekta Evo at Manipal Hospital, Bengaluru
On July 31, 2026, Manipal Hospital, Yelahanka, Bengaluru announced the installation of Elekta Evo, marking the first deployment in India of the company’s AI‑enhanced adaptive CT‑Linac platform. The press release, issued by Elekta via PRNewswire, states that the Evo system enables online adaptive radiotherapy (ART), allowing clinicians to adjust treatment plans in real time based on daily anatomical changes, thereby delivering more personalised and precision‑led radiation therapy.
Cancer Burden Context
The Indian Council of Medical Research (ICMR) estimates that India experiences approximately 1.46 million new cancer cases each year. The growing incidence and the prevalence of complex or advanced‑stage disease underscore the need for technologies that improve treatment precision and personalisation.
Clinical Impact at Manipal Hospital
The hospital reports that the Evo platform has already been used to treat its first patient—a case of locally advanced rectal cancer—through neoadjuvant chemoradiotherapy delivered with online adaptive radiotherapy (oART). The patient completed treatment with minimal radiation‑related side effects, illustrating the platform’s ability to target tumours accurately while sparing surrounding healthy tissue. Ongoing treatments are also being conducted for cervical and prostate cancer patients, with early observations indicating encouraging tolerance and limited side effects.
Technology Features
Elekta Evo integrates Iris™ high‑definition AI‑enhanced imaging with Elekta ONE® Online software. Iris™ provides exceptional visualisation of tumours and adjacent anatomy, while the ONE® suite streamlines adaptive workflows through distributed treatment planning, AI‑assisted contouring, and accelerated dose calculation. The system supports both online and offline adaptive capabilities and can deliver a broad range of radiation therapy techniques on a single platform.
Statements from Leadership
Feras Al Hasan, Head of Region TIMEA at Elekta, said the installation represents a milestone in expanding access to adaptive radiation therapy across India and highlighted the AI‑driven imaging and online adaptive capabilities as tools for more informed treatment decisions. Dr Vikram Maiya, Lead Consultant‑Radiation Oncology at Manipal Hospital, emphasized the hospital’s commitment to bringing cutting‑edge cancer care to patients and noted that the Evo platform enables daily adaptation to anatomical changes, improving individualised treatment outcomes.
Regulatory and Availability Notes
The Elekta Evo system holds registration with the Central Drugs Standard Control Organization (CDSCO) and has limited global availability. Certain components of Elekta ONE® may not yet be available in all markets.
About Elekta
Elekta, listed on Nasdaq Stockholm, employs approximately 4,500 staff worldwide and operates in more than 40 countries. The company positions itself as a leader in precision radiation therapy, focusing on outcome‑driven, cost‑efficient solutions.
About Manipal Hospitals
Manipal Hospitals, part of the Manipal Education and Medical Group (MEMG), operates a network of 49 hospitals across 24 Indian cities, making it the second‑largest hospital chain in the country. The organization manages its extensive network through dedicated entities to ensure high standards of clinical care and patient experience.
Disclaimer: The press release is provided under an arrangement with PRNewswire; PTI assumes no editorial responsibility.